Proteostasis Therapeutics Inc (NASDAQ:PTI)

Delayed Data
As of Jul 18
 +0.03 / +1.08%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Proteostasis Therapeutics Inc have a median target of 12.50, with a high estimate of 25.00 and a low estimate of 5.00. The median estimate represents a +346.43% increase from the last price of 2.80.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Proteostasis Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -59.38%
Growthannually 15.06%


Growthquarterly 38.87%
Growthannually -0.99%
Key to the earnings and sales forecast charts.